0001209191-23-024026.txt : 20230411
0001209191-23-024026.hdr.sgml : 20230411
20230411165918
ACCESSION NUMBER: 0001209191-23-024026
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230410
FILED AS OF DATE: 20230411
DATE AS OF CHANGE: 20230411
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Conterno Enrique A
CENTRAL INDEX KEY: 0001476151
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36740
FILM NUMBER: 23813916
MAIL ADDRESS:
STREET 1: LILLY CORPORATE CENTER
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46285
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FIBROGEN INC
CENTRAL INDEX KEY: 0000921299
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 409 ILLINOIS STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 415-978-1200
MAIL ADDRESS:
STREET 1: 409 ILLINOIS STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-04-10
0
0000921299
FIBROGEN INC
FGEN
0001476151
Conterno Enrique A
C/O FIBROGEN, INC.
409 ILLINOIS STREET
SAN FRANCISCO
CA
94158
1
1
0
0
Chief Executive Officer
0
Common Stock
2023-04-10
4
S
0
1869
19.52
D
382999
D
Common Stock
27800
I
By Trust
Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.
/s/ Cecelia Monoarfa-Taime, Attorney-in-fact
2023-04-11